News Release

Excerpta Medica and Elsevier Interactive Solutions merge into 1 integrated provider

Business Announcement

Elsevier

Bridgewater, NJ, October 12, 2007 -- Excerpta Medica, an Elsevier business that has delivered medical communications for over six decades, has merged with corporate sibling Elsevier Interactive Solutions (EIS), an award-winning interactive health communications agency with more than a decade’s experience creating online marketing and educational programs for leading healthcare brands. Excerpta Medica will now be able to offer customers in the pharmaceutical and biotechnology industries a full range of comprehensive, turn-key communication solutions that combine important and timely clinical content with innovative online tools.

“As the online channel becomes increasingly important to our clients, we can now provide them with seamless access to a proven pioneer in interactive health care marketing,” says Greg Samios, President of Excerpta Medica. “Health care organizations now have a choice: juggle work amongst several agencies for integrated campaigns, or work with us and benefit from the time- and cost-savings of having all the services they need in one organization.”

To reflect the merger, EIS has changed its name to Excerpta Medica Interactive (http://www.ExMInteractive.com/) and will operate as a division of Excerpta Medica. Excerpta Medica Interactive will service clients globally from its offices in Toronto.

###

About Excerpta Medica

Excerpta Medica, an Elsevier business, is a global communications company that services health care clients in the areas of medical education, medical communications, publication planning, and interactive solutions. Excerpta Medica brings an experienced team of professionals from pharmaceuticals, health care, medical publishing and online marketing to deliver scientific and creative solutions. Excerpta Medica (http://www.excerptamedica.com) has offices in the US, The Netherlands, and Canada (http://www.exminteractive.com).

About Elsevier

Elsevier is a world-leading publisher of scientific, technical and medical information products and services. Working in partnership with the global science and health communities, Elsevier's 7,000 employees in over 70 offices worldwide publish more than 2,000 journals and 1,900 new books per year, in addition to offering a suite of innovative electronic products, such as ScienceDirect (http://www.sciencedirect.com/), MD Consult (http://www.mdconsult.com/), Scopus (http://www.info.scopus.com/), bibliographic databases, and online reference works.

Elsevier (http://www.elsevier.com/) is a global business headquartered in Amsterdam, The Netherlands and has offices worldwide. Elsevier is part of Reed Elsevier Group plc (http://www.reedelsevier.com/), a world-leading publisher and information provider. Operating in the science and medical, legal, education and business-to-business sectors, Reed Elsevier provides high-quality and flexible information solutions to users, with increasing emphasis on the Internet as a means of delivery. Reed Elsevier's ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.